Target Lesion Assessment

Illustrates Domains

TU
TR

Illustrates Variables

TULOC
TULAT
TUMETHOD
TRLNKID
TRMETHOD
TRLOBXFL
TREVAL


Content

In this example, 2 target lesions were identified for the subject. The investigator evaluated the erythema, scaling, and elevation severity/intensity of each lesion using a 5-point scale. The sponsor planned to analyze the total severity score (sum of the erythema, scaling, and elevation scores), as well as the individual erythema, scaling, and elevation scores. The total score was derived by the sponsor and is not included in the SDTM dataset.

tu.xpt

tu.xpt

RowSTUDYIDDOMAINUSUBJIDTUSEQTULNKIDTUTESTCDTUTESTTUORRESTUSTRESCTULOCTULATTUMETHODTUEVALVISITNUMTUDTCTUDY
1PS007TU0011
LESIDENTLesion IdentificationTARGET PLAQUE 1TARGET PLAQUE 1ARMLEFTPHYSICAL EXAMINATIONINVESTIGATOR12015-06-15-3
2PS007TU0012
LESIDENTLesion IdentificationTARGET PLAQUE 2TARGET PLAQUE 2ARMRIGHTPHYSICAL EXAMINATIONINVESTIGATOR12015-06-15-3

The target lesions were identified by physical examination (TUMETHOD). The lesions were evaluated using a 5-point numerical rating scale, from 0 = "None", to 4 = "Very Severe." This was represented using TRMETHOD. However, if information on additional methods needs to be represented (e.g., photography with a third-party assessor), an additional method may be included. A sponsor may use "MULTIPLE" in TRMETHOD and represent the methods in the NSVs METHD1 and METHD2 (PHOTOGRAPHY, NUMERICAL RATING SCALE 5-POINT).

tr.xpt
Rows 1-6:Show the erythema, scaling, and elevation severity/intensity scores for target lesion 1 at 2 visits.
Rows 7-12:

Show the erythema, scaling, and elevation severity/intensity scores for target lesion 2 at 2 visits.

tr.xpt

RowSTUDYIDDOMAINUSUBJIDTRSEQTRLNKIDTRTESTCDTRTESTTRORRESTRSTRESCTRSTRESNTRMETHODTRLOBXFLTREVALVISITNUMTRDTC
1PS007TR0011TARGET PLAQUE 1LESERYSVLesion Erythema Severity/IntensitySEVERE33NUMERICAL RATING SCALE 5-POINTYINVESTIGATOR1

2015-06-15

2PS007TR0012TARGET PLAQUE 1LESSCLSVLesion Scaling Severity/IntensitySEVERE33NUMERICAL RATING SCALE 5-POINTYINVESTIGATOR12015-06-15
3PS007TR0013TARGET PLAQUE 1LESELESVLesion Elevation Severity/IntensityMODERATE22NUMERICAL RATING SCALE 5-POINTYINVESTIGATOR12015-06-15
4PS007TR0014TARGET PLAQUE 1LESERYSVLesion Erythema Severity/IntensitySEVERE33NUMERICAL RATING SCALE 5-POINT
INVESTIGATOR2

2015-07-15

5PS007TR0015TARGET PLAQUE 1LESSCLSVLesion Scaling Severity/IntensitySEVERE33NUMERICAL RATING SCALE 5-POINT
INVESTIGATOR22015-07-15
6PS007TR0016TARGET PLAQUE 1LESELESVLesion Elevation Severity/IntensityMODERATE22NUMERICAL RATING SCALE 5-POINT
INVESTIGATOR22015-07-15
7PS007TR0017TARGET PLAQUE 2LESERYSVLesion Erythema Severity/IntensitySEVERE33NUMERICAL RATING SCALE 5-POINTYINVESTIGATOR1

2015-06-15

8PS007TR0018TARGET PLAQUE 2LESSCLSVLesion Scaling Severity/IntensityMILD11NUMERICAL RATING SCALE 5-POINTYINVESTIGATOR12015-06-15
9PS007TR0019TARGET PLAQUE 2LESELESVLesion Elevation Severity/IntensityMILD11NUMERICAL RATING SCALE 5-POINTYINVESTIGATOR12015-06-15
10PS007TR00110TARGET PLAQUE 2LESERYSVLesion Erythema Severity/IntensitySEVERE33NUMERICAL RATING SCALE 5-POINT
INVESTIGATOR2

2015-07-15

11PS007TR00111TARGET PLAQUE 2LESSCLSVLesion Scaling Severity/IntensityMILD11NUMERICAL RATING SCALE 5-POINT
INVESTIGATOR22015-07-15
12PS007TR00112TARGET PLAQUE 2LESELESVLesion Elevation Severity/IntensityMILD11NUMERICAL RATING SCALE 5-POINT
INVESTIGATOR22015-07-15